Decibel Therapeutics Funding: $341M Raised, Series C (2018)
Decibel Therapeutics is based in Boston, MA. It has raised $341M in total funding. Latest round: Series C. Backed by GV, Third Rock Ventures, SR One.
Decibel Therapeutics funding overview
Decibel Therapeutics is based in Boston, MA. Decibel Therapeutics has raised $341M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2018. The round record for Decibel Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include GV, Third Rock Ventures, SR One, Regeneron Pharmaceuticals, Foresite Capital, Bessemer Venture Partners and 3 others. 9 distinct backers are named across the disclosed rounds.
Decibel Therapeutics at a glance
Total raised
$341M
Latest round
Series C
Latest round date
June 2018
Headquarters
Boston, MA
Notable investors
GV, Third Rock Ventures, SR One, Regeneron Pharmaceuticals, Foresite Capital, Bessemer Venture Partners, Schroder Adveq, S-Cubed
Frequently asked about Decibel Therapeutics funding
How much has Decibel Therapeutics raised?
Decibel Therapeutics has raised $341M in total disclosed funding across the rounds on record.
Who has invested in Decibel Therapeutics?
GV, Third Rock Ventures, SR One, Regeneron Pharmaceuticals, Foresite Capital, Bessemer Venture Partners are named among the investors backing Decibel Therapeutics.
What was the latest Decibel Therapeutics funding round?
The most recent disclosed round is a Series C, announced in June 2018.
Where is Decibel Therapeutics based?
Decibel Therapeutics is based in Boston, MA.
When did Decibel Therapeutics last raise?
The last disclosed Decibel Therapeutics round closed in June 2018 at Series C.
Round data for Decibel Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
